UBS AM
RXO icon

UBS AM’s RXO RXO Stock Holding History

UBS AM’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.18M Sell
187,901
-57,702
-23% -$1.27M ﹤0.01% 1594
2026
Q1 		$3.59M Sell
245,603
-31,056
-11% -$456K ﹤0.01% 1741
2025
Q4 		$3.5M Buy
276,659
+32,833
+13% +$484K ﹤0.01% 1640
2025
Q3 		$3.75M Sell
243,826
-146,763
-38% -$2.37M ﹤0.01% 1502
2025
Q2 		$6.14M Buy
390,589
+107,216
+38% +$1.63M ﹤0.01% 1607
2025
Q1 		$5.41M Sell
283,373
-2,131
-0.7% -$46.6K ﹤0.01% 1527
2024
Q4 		$6.81M Buy
285,504
+37,916
+15% +$1.06M ﹤0.01% 1451
2024
Q3 		$6.93M Buy
247,588
+4,415
+2% +$125K ﹤0.01% 1405
2024
Q2 		$6.36M Buy
243,173
+137,547
+130% +$2.86M ﹤0.01% 1358
2024
Q1 		$2.31M Sell
105,626
-13,300
-11% -$285K ﹤0.01% 1619
2023
Q4 		$2.77M Sell
118,926
-7,814
-6% -$157K ﹤0.01% 1526
2023
Q3 		$2.5M Sell
126,740
-96,922
-43% -$1.91M ﹤0.01% 1511
2023
Q2 		$4.39M Hold
223,662
– – ﹤0.01% 1294
2023
Q1 		$4.39M Buy
223,662
+19,890
+10% +$382K ﹤0.01% 1294
2022
Q4 		$3.5M Buy
+203,772
New +$3.61M ﹤0.01% 1296

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

UBS AM's RXO Position: Q2 2026 in Review

UBS AM reduced its RXO (RXO) stake by 23% in Q2 2026, selling an estimated $1.27M and leaving 187,901 shares worth $5.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1594.

UBS AM first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.93M in Q3 2024. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • UBS AM held 187,901 shares of RXO worth $5.18M as of Q2 2026.
  • UBS AM sold 57,702 RXO shares in Q2 2026, an estimated $1.27M.
  • RXO made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1594 holding.
  • UBS AM first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • UBS AM's RXO position peaked at $6.93M in Q3 2024.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.